AI Analyst Brief
conf: low
Whitefort Capital initiates a 13D/A on Arbutus Biopharma (ABUS) with a ~15.8M share stake, representing the first activist position on this issuer in 90 days; the amendment suggests an evolving agenda, though no explicit purpose is disclosed in the extract. High short interest (16.2M shares, DTC 7.04) creates a notable squeeze dynamic if Whitefort pushes for a catalyst.